FR2663336B1
(fr)
|
1990-06-18 |
1992-09-04 |
Adir |
Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
FR2713225B1
(fr)
|
1993-12-02 |
1996-03-01 |
Sanofi Sa |
N-pipéridino-3-pyrazolecarboxamide substitué.
|
US7396814B2
(en)
|
1995-06-07 |
2008-07-08 |
Palatin Technologies, Inc. |
Metallopeptide compositions for treatment of sexual dysfunction
|
CA2241567A1
(fr)
|
1996-01-17 |
1997-07-24 |
Novo Nordisk A/S |
Derives de 1,2,4-thiadiazine fusionnee et de 1,4-thiazine fusionnee, leur preparation et utilisation
|
HU227021B1
(en)
|
1996-08-30 |
2010-05-28 |
Novo Nordisk As |
Glp-1 derivatives
|
HUP0301101A3
(en)
|
1996-12-31 |
2009-03-30 |
Reddy S Res Foundation |
Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
|
DE19726167B4
(de)
|
1997-06-20 |
2008-01-24 |
Sanofi-Aventis Deutschland Gmbh |
Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
|
JP2001510195A
(ja)
|
1997-07-16 |
2001-07-31 |
ノボ ノルディスク アクティーゼルスカブ |
縮合化1,2,4−チアジアジン誘導体、その調製及び使用
|
CO4970713A1
(es)
|
1997-09-19 |
2000-11-07 |
Sanofi Synthelabo |
Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
|
AU756965B2
(en)
|
1998-03-12 |
2003-01-30 |
Microbial Chemistry Research Foundation |
Benzofurylpyrone derivatives
|
US6221897B1
(en)
|
1998-06-10 |
2001-04-24 |
Aventis Pharma Deutschland Gmbh |
Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
|
FR2783246B1
(fr)
|
1998-09-11 |
2000-11-17 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les medicaments les contenant
|
DE19845405C2
(de)
|
1998-10-02 |
2000-07-13 |
Aventis Pharma Gmbh |
Arylsubstituierte Propanolaminderivate und deren Verwendung
|
US6903186B1
(en)
|
1998-12-07 |
2005-06-07 |
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S |
Analogues of GLP-1
|
GB9900416D0
(en)
|
1999-01-08 |
1999-02-24 |
Alizyme Therapeutics Ltd |
Inhibitors
|
WO2000058491A1
(fr)
|
1999-03-25 |
2000-10-05 |
The Kitasato Institute |
Nouvelles substances kf-1040t4a, kf-1040t4b, kf-1040t5a et kf-1040t5b et leur procede de production
|
EP1173438A1
(fr)
|
1999-04-16 |
2002-01-23 |
Novo Nordisk A/S |
Imidazoles substitues, leur preparation et utilisation
|
AU3957600A
(en)
|
1999-04-26 |
2000-11-10 |
Boehringer Ingelheim International Gmbh |
Piperidyl-imidazole derivatives, their preparations and therapeutic uses
|
KR100693771B1
(ko)
|
1999-04-28 |
2007-03-12 |
사노피-아벤티스 도이칠란트 게엠베하 |
Ppar 수용체 리간드로서의 트리아릴 산 유도체 및 이를 포함하는 약제학적 조성물
|
CZ20013833A3
(cs)
|
1999-04-28 |
2002-02-13 |
Aventis Pharma Deutschland Gmbh |
Deriváty kyselin se dvěma arylovými zbytky jako ligandy receptorů PPAR a farmaceutické prostředky, které je obsahují
|
WO2000066585A1
(fr)
|
1999-04-30 |
2000-11-09 |
Neurogen Corporation |
Derives 9h-pyrimido[4,5-b]indoles: ligands specifiques de crf1
|
GB9911863D0
(en)
|
1999-05-21 |
1999-07-21 |
Knoll Ag |
Therapeutic agents
|
AU5737900A
(en)
|
1999-06-15 |
2001-01-02 |
Du Pont Pharmaceuticals Company |
Substituted heterocycle fused gamma-carbolines
|
AU769350B2
(en)
|
1999-06-23 |
2004-01-22 |
Sanofi-Aventis Deutschland Gmbh |
Substituted benzimidazole
|
EP1076066A1
(fr)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides abaissant le taux de glucose sanguin
|
JP2003506365A
(ja)
|
1999-07-29 |
2003-02-18 |
イーライ・リリー・アンド・カンパニー |
ベンゾフリルピペラジンおよびベンゾフリルホモピペラジン:セロトニンアゴニスト
|
CZ2002767A3
(cs)
|
1999-09-01 |
2002-06-12 |
Aventis Pharma Deutschland Gmbh |
Sulfonylkarboxamidové deriváty, způsob jejich přípravy a jejich pouľití jako léčiv
|
AU7476800A
(en)
|
1999-09-10 |
2001-04-10 |
Novo Nordisk A/S |
Method of inhibiting protein tyrosine phosphatase 1b and/or t-cell protein tyrosine phosphatase and/or other ptpases with an asp residue at position 48
|
AU6985200A
(en)
|
1999-09-10 |
2001-04-17 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphatases (ptpases)
|
DE19951360A1
(de)
|
1999-10-26 |
2001-05-03 |
Aventis Pharma Gmbh |
Substituierte Indole
|
FR2800375B1
(fr)
|
1999-11-03 |
2004-07-23 |
Sanofi Synthelabo |
Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant
|
PE20011010A1
(es)
|
1999-12-02 |
2001-10-18 |
Glaxo Group Ltd |
Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
|
FR2805817B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
|
FR2805818B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
|
DK1268435T3
(da)
|
2000-03-23 |
2007-03-12 |
Solvay Pharm Bv |
4,5-dihydro-1H-pyrazolderivater med CB1-antagonistisk aktivitet
|
IL151376A0
(en)
|
2000-03-31 |
2003-04-10 |
Pfizer Prod Inc |
Malonamic acids and derivatives thereof as thyroid receptor ligands
|
DK1277736T3
(da)
|
2000-04-28 |
2007-10-01 |
Asahi Kasei Pharma Corp |
Hidtil ukendte bicykliske forbindelser
|
AU779266B2
(en)
|
2000-05-11 |
2005-01-13 |
Banyu Pharmaceutical Co., Ltd. |
N-acyltetrahydroisoquinoline derivatives
|
ES2252230T3
(es)
|
2000-05-11 |
2006-05-16 |
Bristol-Myers Squibb Company |
Analogos de tetrahidroisoquinolina utiles como secretores de la hormona del crecimiento.
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
CA2410597A1
(fr)
|
2000-05-30 |
2001-12-06 |
Merck & Co., Inc. |
Agonistes du recepteur de la melanocortine
|
US6395784B1
(en)
|
2000-06-07 |
2002-05-28 |
Bristol-Myers Squibb Company |
Benzamide ligands for the thyroid receptor
|
DE60110066T2
(de)
|
2000-06-16 |
2006-02-02 |
Smithkline Beecham P.L.C., Brentford |
Piperidine zur verwendung als orexinrezeptorantagonisten
|
EP1246847A2
(fr)
|
2000-07-05 |
2002-10-09 |
Synaptic Pharmaceutical Corporation |
Adn codant pour un recepteur humain de l'hormone de concentration de la melanine (mch1) et ses applications
|
WO2002006245A1
(fr)
|
2000-07-05 |
2002-01-24 |
Synaptic Pharmarceutical Corporation |
Antagonistes selectifs des recepteurs (mch1) d'hormone-1 de concentration de la melanine et utilisation de ceux-ci
|
DE60106641T2
(de)
|
2000-11-03 |
2005-12-01 |
Wyeth |
Cyclopenta[b][1,4] diazepino[6,7,1-hi]indole als 5ht2c antagonisten
|
JP2004513164A
(ja)
|
2000-11-10 |
2004-04-30 |
イーライ・リリー・アンド・カンパニー |
3−置換オキシインドールβ3アゴニスト
|
HUP0004741A2
(hu)
|
2000-11-28 |
2002-12-28 |
Sanofi-Synthelabo |
Kémiai eljárás tiazolszármazékok előállítására és új intermedier
|
IL156552A0
(en)
|
2000-12-21 |
2004-01-04 |
Aventis Pharma Gmbh |
Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
|
ATE528303T1
(de)
|
2000-12-21 |
2011-10-15 |
Vertex Pharma |
Pyrazoleverbindungen als proteinkinasehemmer
|
IL156548A0
(en)
|
2000-12-21 |
2004-01-04 |
Aventis Pharma Gmbh |
Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
|
TWI291957B
(en)
|
2001-02-23 |
2008-01-01 |
Kotobuki Pharmaceutical Co Ltd |
Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
|
EP1373216B1
(fr)
|
2001-03-22 |
2004-12-15 |
Solvay Pharmaceuticals B.V. |
Derives de 4,5-dihydro-1h-pyrazole ayant une activite d'antagoniste de cb 1
|
JP2004529161A
(ja)
|
2001-05-04 |
2004-09-24 |
トゥラリック インコーポレイテッド |
縮合複素環式化合物
|
GB0113233D0
(en)
|
2001-05-31 |
2001-07-25 |
Glaxo Group Ltd |
Chemical compounds
|
ATE417947T1
(de)
|
2001-06-28 |
2009-01-15 |
Alonim Holding Agricultural Co |
Behandlung für verbesserte oberflächenkorrosionsbeständigkeit von magnesium
|
JP2004536104A
(ja)
|
2001-07-05 |
2004-12-02 |
シナプティック・ファーマスーティカル・コーポレーション |
Mch選択的アンタゴニストとしての置換されたアニリン−ピペリジン誘導体
|
AU2002319627A1
(en)
|
2001-07-20 |
2003-03-03 |
Merck And Co., Inc. |
Substituted imidazoles as cannabinoid receptor modulators
|
US7718802B2
(en)
|
2001-08-10 |
2010-05-18 |
Palatin Technologies, Inc. |
Substituted melanocortin receptor-specific piperazine compounds
|
US7732451B2
(en)
|
2001-08-10 |
2010-06-08 |
Palatin Technologies, Inc. |
Naphthalene-containing melanocortin receptor-specific small molecule
|
EP1425029A4
(fr)
|
2001-08-10 |
2006-06-07 |
Palatin Technologies Inc |
Peptidomimetiques de metallopeptides biologiquement actifs
|
US7655658B2
(en)
|
2001-08-10 |
2010-02-02 |
Palatin Technologies, Inc. |
Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
|
DE10139416A1
(de)
|
2001-08-17 |
2003-03-06 |
Aventis Pharma Gmbh |
Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
KR100915108B1
(ko)
|
2001-08-31 |
2009-09-03 |
사노피-아벤티스 도이칠란트 게엠베하 |
Ppar-활성화제로서의 디아릴사이클로알킬 유도체 및 이를 포함하는 약제학적 조성물
|
US7109216B2
(en)
|
2001-09-21 |
2006-09-19 |
Solvay Pharmaceuticals B.V. |
1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
|
US6509367B1
(en)
|
2001-09-22 |
2003-01-21 |
Virginia Commonwealth University |
Pyrazole cannabinoid agonist and antagonists
|
HN2002000266A
(es)
|
2001-09-24 |
2003-11-16 |
Bayer Corp |
Preparacion y uso de derivados de imidazol para el tratamiento de la obesidad.
|
US20040267028A1
(en)
|
2001-09-24 |
2004-12-30 |
Smith Roger A |
Preparation and use of pyrrole derivatives for treating obesity
|
GB0124627D0
(en)
|
2001-10-15 |
2001-12-05 |
Smithkline Beecham Plc |
Novel compounds
|
CA2466490C
(fr)
|
2001-11-22 |
2009-12-29 |
Biovitrum Ab |
Inhibiteurs de la 11-beta-hydroxysteroide deshydrogenase de type 1
|
CA2466491A1
(fr)
|
2001-11-22 |
2003-05-30 |
Biovitrum Ab |
Inhibiteurs de la 11-beta-hydroxysteroide deshydrogenase de type 1
|
KR20050044517A
(ko)
|
2001-11-22 |
2005-05-12 |
바이오비트럼 에이비 |
11-베타-히드록시 스테로이드 탈수소효소 유형 1 의억제제
|
GB0202015D0
(en)
|
2002-01-29 |
2002-03-13 |
Hoffmann La Roche |
Piperazine Derivatives
|
JP4368683B2
(ja)
|
2002-02-01 |
2009-11-18 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病、肥満症および脂質代謝異常の治療に有用な11−ベータ−ヒドロキシステロイドデヒドロゲナーゼ1阻害剤
|
US20050124652A1
(en)
|
2002-02-04 |
2005-06-09 |
Rustum Boyce |
Guanidino compounds
|
EA200400980A1
(ru)
|
2002-02-27 |
2005-02-24 |
Пфайзер Продактс Инк. |
Ингибиторы асс
|
ATE346070T1
(de)
|
2002-03-05 |
2006-12-15 |
Lilly Co Eli |
Purinderivate als kinaseinhibitoren
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
FR2836915B1
(fr)
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
CA2480856A1
(fr)
|
2002-04-05 |
2003-10-23 |
Merck & Co., Inc. |
Arylamides substituee
|
FR2838439B1
(fr)
|
2002-04-11 |
2005-05-20 |
Sanofi Synthelabo |
Derives de terphenyle, leur preparation, les compositions pharmaceutqiues en contenant
|
GB0208384D0
(en)
|
2002-04-11 |
2002-05-22 |
Karobio Ab |
Novel compounds
|
DE10215907A1
(de)
|
2002-04-11 |
2003-11-06 |
Aventis Pharma Gmbh |
Acyl-4-carboxyphenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
|
FR2838438A1
(fr)
|
2002-04-11 |
2003-10-17 |
Sanofi Synthelabo |
Derives de diphenylpyridine,leur preparation, les compositions pharmaceutiques en contenant
|
EP1499306A4
(fr)
|
2002-04-12 |
2007-03-28 |
Merck & Co Inc |
Amides bicycliques
|
WO2003097064A1
(fr)
|
2002-05-17 |
2003-11-27 |
Kyowa Hakko Kogyo Co., Ltd. |
Agent de traitement du diabète
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
DE10226462A1
(de)
|
2002-06-13 |
2003-12-24 |
Aventis Pharma Gmbh |
Fluorierte Cycloalkyl-derivatisierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
HUP0202001A2
(hu)
|
2002-06-14 |
2005-08-29 |
Sanofi-Aventis |
DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok
|
DE10227508A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Säuregruppen-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
DE10227507A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Kationisch substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
DE10227506A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
US20040002524A1
(en)
|
2002-06-24 |
2004-01-01 |
Richard Chesworth |
Benzimidazole compounds and their use as estrogen agonists/antagonists
|
AU2003248888A1
(en)
|
2002-07-09 |
2004-01-23 |
Palatin Technologies, Inc. |
Peptide composition for treatment of sexual dysfunction
|
US7649012B2
(en)
|
2002-07-09 |
2010-01-19 |
Fasgen, Inc. |
Compounds, pharmaceutical compositions containing same, and methods of use for same
|
DE10231370B4
(de)
|
2002-07-11 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
PL373329A1
(en)
|
2002-07-12 |
2005-08-22 |
Sanofi-Aventis Deutschland Gmbh |
Heterocyclically substituted benzoylureas, method for their production and their use as medicaments
|
DE10233817A1
(de)
|
2002-07-25 |
2004-02-12 |
Aventis Pharma Deutschland Gmbh |
Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2004011410A1
(fr)
|
2002-07-27 |
2004-02-05 |
Astrazeneca Ab |
Composes chimiques
|
WO2004013120A1
(fr)
|
2002-07-29 |
2004-02-12 |
F. Hoffmann-La Roche Ag |
Nouveaux benzodioxoles
|
BR0313262A
(pt)
|
2002-08-07 |
2005-07-12 |
Mitsubishi Pharma Corp |
Compostos de dihidropirazolpiridina
|
GB0219022D0
(en)
|
2002-08-15 |
2002-09-25 |
Karobio Ab |
Novel thyromimetic compounds
|
DE10237722A1
(de)
|
2002-08-17 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
|
EP1537087B1
(fr)
|
2002-09-05 |
2012-11-28 |
Aventis Pharma S.A. |
Derives de 3-aminoindazole comme inhibiteurs de kinase et compositions pharmaceutiques les renfermant
|
AU2003268493A1
(en)
|
2002-09-11 |
2004-04-30 |
Merck & Co., Inc. |
Piperazine urea derivatives as melanocortin-4 receptor agonists
|
JP2006510597A
(ja)
|
2002-09-27 |
2006-03-30 |
メルク エンド カムパニー インコーポレーテッド |
置換ピリミジン類
|
JP2006506451A
(ja)
|
2002-10-11 |
2006-02-23 |
アストラゼネカ アクチボラグ |
1,4−ジ置換ピペリジン誘導体および11−βHSD1阻害薬としてのそれらの使用
|
KR20050067418A
(ko)
|
2002-10-18 |
2005-07-01 |
머크 앤드 캄파니 인코포레이티드 |
당뇨병을 치료 또는 예방하기 위한 베타-아미노헤테로사이클릭 디펩티딜 펩티다제 억제제
|
EP1556373A1
(fr)
|
2002-10-18 |
2005-07-27 |
Pfizer Products Inc. |
Ligands des recepteurs des cannabinoides et applications de ceux-ci
|
US7132539B2
(en)
|
2002-10-23 |
2006-11-07 |
The Procter & Gamble Company |
Melanocortin receptor ligands
|
MXPA05004434A
(es)
|
2002-10-24 |
2005-07-26 |
Sterix Ltd |
Inhibidores de 11-beta-hidroxi esteroide deshidrogenasa tipo 1 y tipo 2.
|
DE10250708A1
(de)
|
2002-10-31 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
WO2004041274A1
(fr)
|
2002-11-05 |
2004-05-21 |
Arena Pharmaceuticals, Inc. |
Benzotriazoles et procedes de prevention ou de traitement des troubles metabolique
|
US20060058315A1
(en)
|
2002-11-07 |
2006-03-16 |
Astrazeneca Ab |
2-Oxo-ethanesulfonamide derivates
|
FR2847253B1
(fr)
|
2002-11-19 |
2007-05-18 |
Aventis Pharma Sa |
Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant
|
MY134457A
(en)
|
2002-11-22 |
2007-12-31 |
Merck & Co Inc |
Substituted amides
|
GB0227813D0
(en)
|
2002-11-29 |
2003-01-08 |
Astrazeneca Ab |
Chemical compounds
|
UY28103A1
(es)
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
|
DE10258007B4
(de)
|
2002-12-12 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
DE10258008B4
(de)
|
2002-12-12 |
2006-02-02 |
Sanofi-Aventis Deutschland Gmbh |
Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
AU2003300967B2
(en)
|
2002-12-19 |
2009-05-28 |
Merck Sharp & Dohme Corp. |
Substituted amides
|
JO2397B1
(en)
|
2002-12-20 |
2007-06-17 |
ميرك شارب اند دوم كوربوريشن |
Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
|
AU2003299791A1
(en)
|
2002-12-20 |
2004-07-22 |
Bayer Pharmaceuticals Corporation |
Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
|
WO2004056744A1
(fr)
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides utilises comme inhibiteurs de la hydroxysteroide deshydrogenase
|
FR2849032B1
(fr)
|
2002-12-23 |
2006-04-28 |
Sanofi Synthelabo |
Derive de 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-n -(piperidin-1-yl)-1h-pyrazole-3-carboxamide, sa preparation, son application en therapeuthique
|
GB0230087D0
(en)
|
2002-12-24 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
GB0230088D0
(en)
|
2002-12-24 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
WO2004063179A1
(fr)
|
2003-01-06 |
2004-07-29 |
Eli Lilly And Company |
Arylcyclopropylacetamides substitues servant d'activateurs de glucokinase
|
ES2295816T3
(es)
|
2003-01-14 |
2008-04-16 |
Arena Pharmaceuticals, Inc. |
Derivados arilo y heteroarilo 1,2,3-trisustituidos como moduladores del metabolismo, y profilaxis y tratamiento de transtornos relacionados con los mismos, tales como la diabetes y la hiperglucemia.
|
TW200503994A
(en)
|
2003-01-24 |
2005-02-01 |
Novartis Ag |
Organic compounds
|
WO2004089470A2
(fr)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
Utilisation pharmaceutique d'amides substitues
|
US7176210B2
(en)
|
2003-02-10 |
2007-02-13 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
PL378117A1
(pl)
|
2003-02-11 |
2006-03-06 |
Prosidion Limited |
Tricyklopodstawione związki amidowe
|
EP1594863A1
(fr)
|
2003-02-11 |
2005-11-16 |
Prosidion Limited |
Composes d'amide a substitution tri(cyclo), activateurs de la glucokinase
|
DE502004011328D1
(de)
|
2003-02-13 |
2010-08-12 |
Sanofi Aventis Deutschland |
Substituierte hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
DE502004007000D1
(de)
|
2003-02-13 |
2008-06-12 |
Sanofi Aventis Deutschland |
Stickstoff substituierte hexahydro-pyrazino 1,2-a pyrimidin-4,7-dionderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
DE10306250A1
(de)
|
2003-02-14 |
2004-09-09 |
Aventis Pharma Deutschland Gmbh |
Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
CN100361992C
(zh)
|
2003-02-19 |
2008-01-16 |
霍夫曼-拉罗奇有限公司 |
用作pepck抑制剂的磺酰胺取代的黄嘌呤
|
WO2004078717A1
(fr)
|
2003-03-03 |
2004-09-16 |
Merck & Co., Inc. |
Derives de piperazine acylee tenant lieu d'agonistes du recepteur de la melanocortine-4
|
EP1460069A1
(fr)
|
2003-03-20 |
2004-09-22 |
MyoContract Ltd. |
Dérivés substitués du cyclohexane et de la pipéridine comme modulateurs du récepteur de la melanocortine-4
|
US20040185559A1
(en)
|
2003-03-21 |
2004-09-23 |
Isis Pharmaceuticals Inc. |
Modulation of diacylglycerol acyltransferase 1 expression
|
EP1460075A1
(fr)
|
2003-03-21 |
2004-09-22 |
Sanofi-Synthelabo |
Derivées substituées de 8-perfluoro-6,7,8,9-tetrahydropyrimido[1,2a]pyrimidin-4-one
|
DE602004028228D1
(de)
|
2003-03-26 |
2010-09-02 |
Merck Sharp & Dohme |
Bicyclische piperidin-derivate als melanocortin-4 rezeptor-agonisten
|
CN100432056C
(zh)
|
2003-03-26 |
2008-11-12 |
埃科特莱茵药品有限公司 |
四氢异喹啉基乙酰胺衍生物作为阿立新受体拮抗剂的应用
|
WO2004089380A2
(fr)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
Utilisation pharmaceutique de 1,2,4-triazoles fusionnes
|
EP1615637A1
(fr)
|
2003-04-11 |
2006-01-18 |
Novo Nordisk A/S |
Utilisation pharmaceutique de 1,2,4-triazoles substituees
|
MXPA05010859A
(es)
|
2003-04-11 |
2005-12-14 |
Smithkline Beecham Corp |
Antagonistas mchr1 heterociclicos.
|
US20040214856A1
(en)
|
2003-04-23 |
2004-10-28 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
US7268133B2
(en)
|
2003-04-23 |
2007-09-11 |
Pfizer, Inc. Patent Department |
Cannabinoid receptor ligands and uses thereof
|
US7145012B2
(en)
|
2003-04-23 |
2006-12-05 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
CN100472485C
(zh)
|
2003-04-25 |
2009-03-25 |
松下电器产业株式会社 |
服务器及服务器的处理方法
|
US7049323B2
(en)
|
2003-04-25 |
2006-05-23 |
Bristol-Myers Squibb Company |
Amidoheterocycles as modulators of the melanocortin-4 receptor
|
WO2004096794A1
(fr)
|
2003-05-01 |
2004-11-11 |
Vernalis Research Limited |
Derives azetidinecarboxamide et leur utilisation pour le traitement de troubles a mediation du recepteur du cb1
|
EA010583B1
(ru)
|
2003-05-01 |
2008-10-30 |
Вернэлис Рисёч Лимитед |
Производные азетидинкарбоксамида и их применение при лечении нарушений, опосредованных св1 рецепторами
|
JP2006525297A
(ja)
|
2003-05-01 |
2006-11-09 |
ヴァーナリス リサーチ リミテッド |
治療におけるアゼチジンカルボキサミド誘導体の使用
|
BRPI0410289A
(pt)
|
2003-05-07 |
2006-05-16 |
Pfizer Prod Inc |
ligantes do receptor de canabinóides e suas utilizações
|
AR044152A1
(es)
|
2003-05-09 |
2005-08-24 |
Bayer Corp |
Derivados de alquilarilo, metodo de preparacion y uso para el tratamiento de la obesidad
|
EP1626717A4
(fr)
|
2003-05-09 |
2009-09-09 |
Merck & Co Inc |
Benzimidazoles, compositions contenant lesdits composes et methodes d'utilisation
|
US7067529B2
(en)
|
2003-05-19 |
2006-06-27 |
Hoffmann-La Roche Inc. |
Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors
|
CA2525945A1
(fr)
|
2003-05-21 |
2004-12-02 |
Biovitrum Ab |
Inhibiteurs de 11-beta-hydroxy steroide deshydrogenase de type i
|
EP1651229A1
(fr)
|
2003-05-23 |
2006-05-03 |
Chiron Corporation |
Composes de quinazoline substitues par guanidino constituant des agonistes de mc4-r
|
JP4499106B2
(ja)
|
2003-05-29 |
2010-07-07 |
メルク・シャープ・エンド・ドーム・コーポレイション |
11−ベータ−水酸化ステロイド脱水素酵素−1の阻害剤としてのトリアゾール誘導体
|
WO2004106343A2
(fr)
|
2003-05-30 |
2004-12-09 |
Ufc Limited |
Molecules et analogues de la famille agelastatine d'alkaloides antitumuraux et inhibiteurs de gsk-3?
|
JP2004359630A
(ja)
|
2003-06-06 |
2004-12-24 |
Yamanouchi Pharmaceut Co Ltd |
ジフルオロジフェニルメタン誘導体及びその塩
|
US7232823B2
(en)
|
2003-06-09 |
2007-06-19 |
Pfizer, Inc. |
Cannabinoid receptor ligands and uses thereof
|
US7485732B2
(en)
|
2003-06-11 |
2009-02-03 |
Merck & Co., Inc. |
Substituted 3-alkyl and 3-alkenyl azetidine derivatives
|
US20040253319A1
(en)
|
2003-06-11 |
2004-12-16 |
Shrirang Netke |
Pharmaceutical compositions and method for alleviating side-effects of estrogen replacement therapy
|
DE602004016174D1
(de)
|
2003-06-13 |
2008-10-09 |
Janssen Pharmaceutica Nv |
Substituierte indazolyl(indolyl)maleimid-derivate als kinase inhibitoren
|
US20040259887A1
(en)
|
2003-06-18 |
2004-12-23 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
JP2006527773A
(ja)
|
2003-06-19 |
2006-12-07 |
イーライ リリー アンド カンパニー |
メラノコルチン受容体4(mc4)作用薬とその用途
|
CN100368407C
(zh)
|
2003-06-20 |
2008-02-13 |
霍夫曼-拉罗奇有限公司 |
作为cb1受体反激动剂的2-酰氨基苯并噻唑
|
WO2004113310A1
(fr)
|
2003-06-25 |
2004-12-29 |
Biovitrum Ab |
Utilisation d'un inhibiteur de compose de type 1 11-b-hydroxysteroide deshydrogenase type 1 destine a faciliter la cicatrisation d'une plaie
|
SE0301886D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use V
|
SE0301882D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use I
|
FR2856683A1
(fr)
|
2003-06-25 |
2004-12-31 |
Sanofi Synthelabo |
Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application en therapeutique
|
SE0301888D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use VII
|
US7745822B2
(en)
|
2003-06-27 |
2010-06-29 |
Nec Corporation |
Thin film transistor and thin film transistor substrate including a polycrystalline semiconductor thin film having a large heat capacity part and a small heat capacity part
|
JP2005015434A
(ja)
|
2003-06-27 |
2005-01-20 |
Kotobuki Seiyaku Kk |
血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
|
WO2005000974A2
(fr)
|
2003-06-27 |
2005-01-06 |
Day-Glo Color Corp. |
Composition de marquage a pulveriser a base d'eau
|
CA2531836A1
(fr)
|
2003-07-09 |
2005-01-20 |
Forbes Medi-Tech Inc. |
Nouveaux composes et compositions comprenant des sterols et/ou des stanols et des inhibiteurs de biosynthese du cholesterol et utilisation associees pour le traitement et la prevention de maladies et d'etats divers
|
DE10331074A1
(de)
|
2003-07-09 |
2005-02-03 |
Conti Temic Microelectronic Gmbh |
Sensoranordnung zur Abstands- und/oder Geschwindigkeitsmessung
|
EP1644411A2
(fr)
|
2003-07-11 |
2006-04-12 |
Novo Nordisk A/S |
Compositions d'insuline stabilisee
|
WO2005007628A1
(fr)
|
2003-07-11 |
2005-01-27 |
Bristol-Myers Squibb Company |
Derives de tetrahydroquinoleine constituant des modulateurs des recepteurs des cannabinoides
|
FR2857570A1
(fr)
|
2003-07-18 |
2005-01-21 |
Didier Leandri |
Dispositif de suspension de verres a pied autour d'un seau utilisable pour le rafraichissement des boissons
|
JP2006528180A
(ja)
|
2003-07-22 |
2006-12-14 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン−4受容体作働薬としてのピペリジン誘導体
|
PE20050249A1
(es)
|
2003-07-25 |
2005-06-01 |
Aventis Pharma Gmbh |
Nuevas cianopirrolididas y procedimiento para su preparacion como medicamentos
|
DE10333935A1
(de)
|
2003-07-25 |
2005-02-24 |
Aventis Pharma Deutschland Gmbh |
Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE10334309A1
(de)
|
2003-07-28 |
2005-03-03 |
Aventis Pharma Deutschland Gmbh |
Substituierte Thiazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
US20050026984A1
(en)
|
2003-07-29 |
2005-02-03 |
Aventis Pharma S.A. |
Substituted thieno [2,3-c] pyrazoles and their use as medicinal products
|
US7008953B2
(en)
|
2003-07-30 |
2006-03-07 |
Agouron Pharmaceuticals, Inc. |
3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
EP1653949A4
(fr)
|
2003-08-07 |
2009-04-22 |
Merck & Co Inc |
Carboxamides de pyrazole utilises comme inhibiteurs de la dehydrogenase-1 11-beta-hydroxysteroide
|
WO2005013907A2
(fr)
|
2003-08-07 |
2005-02-17 |
Japan Tobacco Inc. |
Derives de pyrrolo[1,2-b]pyridazine
|
TW200510324A
(en)
|
2003-08-11 |
2005-03-16 |
Lilly Co Eli |
6-(2,2,2-trifluoroethylamino)-7-chiloro-2, 3, 4, 5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist
|
MXPA06001638A
(es)
|
2003-08-13 |
2006-04-28 |
Amgen Inc |
Antagonistas del receptor de la hormona concentradora de melanina.
|
US7326706B2
(en)
|
2003-08-15 |
2008-02-05 |
Bristol-Myers Squibb Company |
Pyrazine modulators of cannabinoid receptors
|
US20070072812A1
(en)
|
2003-08-25 |
2007-03-29 |
Microbia, Inc. |
Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
|
EP1660446A2
(fr)
|
2003-08-28 |
2006-05-31 |
Microbia, Inc. |
Trimeres et dimeres fixes de 1,4-diphenylazetidin-2-ones
|
EP1663113A4
(fr)
|
2003-09-18 |
2007-06-13 |
Merck & Co Inc |
Sulfonamides substitues
|
CA2539253A1
(fr)
|
2003-09-19 |
2005-03-31 |
Novo Nordisk A/S |
Nouveaux derives de glp-1
|
TWI336697B
(en)
|
2003-09-19 |
2011-02-01 |
Solvay Pharm Bv |
Thiazole derivatives as cannabinoid receptor modulators
|
US20050070712A1
(en)
|
2003-09-26 |
2005-03-31 |
Christi Kosogof |
Pyrimidine derivatives as ghrelin receptor modulators
|
BRPI0414890A
(pt)
|
2003-09-30 |
2006-12-12 |
Novo Nordisk As |
composto, métodos de retardar a progressão de igt para diabete tipo 2, e de diabete tipo 2 para diabete que requer insulina, de tratar a obesidade ou prevenir o excesso de peso, de regular o apetite, de induzir saciedade, de impedir o ganho de peso, de aumentar o gasto de energia, e de tratar uma doença ou estado, composição farmacêutica, e, uso de um composto
|
EP1522541A1
(fr)
|
2003-10-07 |
2005-04-13 |
Lipideon Biotechnology AG |
Nouveaux composés hypocholesterolémiques
|
US7244843B2
(en)
|
2003-10-07 |
2007-07-17 |
Bristol-Myers Squibb Company |
Modulators of serotonin receptors
|
WO2005042516A2
(fr)
|
2003-10-22 |
2005-05-12 |
Neurocrine Biosciences, Inc. |
Ligands de recepteurs de la melanocortine, compositions et procedes associes
|
WO2005040109A1
(fr)
|
2003-10-22 |
2005-05-06 |
Neurocrine Biosciences, Inc. |
Ligands du recepteur de la melanocortine et compositions et methodes associees
|
GB0325192D0
(en)
|
2003-10-29 |
2003-12-03 |
Astrazeneca Ab |
Method of use
|
WO2005044256A1
(fr)
|
2003-10-30 |
2005-05-19 |
Merck & Co., Inc. |
Composes de 2-azetidinones utilises comme agents pour lutter contre une hypercholesterolemie
|
GB0325402D0
(en)
|
2003-10-31 |
2003-12-03 |
Astrazeneca Ab |
Compounds
|
WO2005042692A2
(fr)
|
2003-10-31 |
2005-05-12 |
Forbes Medi-Tech Inc. |
Methode permettant d'inhiber l'expression de genes qui induisent l'influx de cholesterol cellulaire dans les cellules animales et d'inhiber la production de proteines issues de l'expression de ces genes
|
ES2291951T3
(es)
|
2003-11-07 |
2008-03-01 |
F. Hoffmann-La Roche Ag |
Derivados de benzo (b) (1,4) dioxepina.
|
PT1682499E
(pt)
|
2003-11-10 |
2007-11-05 |
Microbia Inc |
4-biarilil-1-fenilazetidin-2-onas
|
JP4795965B2
(ja)
|
2003-11-12 |
2011-10-19 |
エルジー・ライフ・サイエンシーズ・リミテッド |
メラノコルチン受容体のアゴニスト
|
KR20050045927A
(ko)
|
2003-11-12 |
2005-05-17 |
주식회사 엘지생명과학 |
멜라노코틴 수용체의 항진제
|
US7368453B2
(en)
|
2003-11-19 |
2008-05-06 |
Chiron Corporation |
Quinazolinone compounds with reduced bioaccumulation
|
EP1538159A1
(fr)
|
2003-12-05 |
2005-06-08 |
Santhera Pharmaceuticals (Schweiz) GmbH |
Dérivés de N-benzyl-lactam comme agonistes du récepteur melanocortine-4
|
US20070155660A1
(en)
|
2003-12-10 |
2007-07-05 |
Marsh Donald J |
Inhibition of voluntary ethanol consumption with selective melanocortin 4-receptor agonists
|
DE10359098A1
(de)
|
2003-12-17 |
2005-07-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-(Piperazin-1-yl)- und 2-([1,4]Diazepan-1-yl)-imidazo[4,5-d]pyridazin-4-one, deren Herstellung und deren Verwendung als Arzneimittel
|
EP1557417B1
(fr)
|
2003-12-19 |
2007-03-07 |
Sanofi-Aventis |
Dérivés de 8'-pyri(mi)dinyl-dihydrospiro-[cycloaklyamine]-pyrimido[1,2-a]pyrimidin-6-one substitués
|
TW200530246A
(en)
|
2003-12-19 |
2005-09-16 |
Bristol Myers Squibb Co |
Azabicyclic heterocycles as cannabinoid receptor modulators
|
JP2007514794A
(ja)
|
2003-12-19 |
2007-06-07 |
メルク エンド カムパニー インコーポレーテッド |
環式グアニジン、そのような化合物を含む組成、及び使用方法
|
CA2545506A1
(fr)
|
2003-12-19 |
2005-06-30 |
Biovitrum Ab |
Nouveaux derives de benzofurane, pouvant etre utilises dans la prophylaxie ou le traitement des affections associees au recepteur de 5-ht6
|
WO2005062824A2
(fr)
|
2003-12-23 |
2005-07-14 |
Merck & Co., Inc. |
Composes anti-hypercholesterolemie
|
GB0329778D0
(en)
|
2003-12-23 |
2004-01-28 |
Astrazeneca Ab |
Chemical compounds
|
US7871998B2
(en)
|
2003-12-23 |
2011-01-18 |
Astrazeneca Ab |
Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity
|
AU2004303604B2
(en)
|
2003-12-24 |
2011-03-24 |
Prosidion Limited |
Heterocyclic derivatives as GPCR receptor agonists
|
JP2005206492A
(ja)
|
2004-01-21 |
2005-08-04 |
Sankyo Co Ltd |
スルホンアミド化合物
|
DE102004003811A1
(de)
|
2004-01-25 |
2005-08-11 |
Aventis Pharma Deutschland Gmbh |
Substituierte N-Cyclohexylimidazolinone, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102004003812A1
(de)
|
2004-01-25 |
2005-08-11 |
Aventis Pharma Deutschland Gmbh |
Arylsubstituierte Heterozyklen, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel
|
JP4436369B2
(ja)
|
2004-01-28 |
2010-03-24 |
エフ.ホフマン−ラ ロシュ アーゲー |
スピロ−ベンゾジオキソール類およびそれらのcb1アンタゴニストとしての使用
|
AU2005209115A1
(en)
|
2004-01-30 |
2005-08-11 |
Japan Tobacco Inc. |
Anorectic compounds
|
DE102004005172A1
(de)
|
2004-02-02 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
|
HUP0400405A3
(en)
|
2004-02-10 |
2009-03-30 |
Sanofi Synthelabo |
Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
|
DE102004006325A1
(de)
|
2004-02-10 |
2005-08-25 |
Bayer Healthcare Ag |
Tetrahydrobenzo[d]azepin-2-on-Derivate und ihre Verwendung
|
FR2866340B1
(fr)
|
2004-02-13 |
2006-11-24 |
Sanofi Synthelabo |
Derives d'oxazole, leur preparation et leur utilisation en therapeutique.
|
WO2005077897A1
(fr)
|
2004-02-17 |
2005-08-25 |
Laboratorios Del Dr. Esteve S.A. |
Composes d'azetidine substitues, preparation et utilisation comme medicaments
|
EP1718625A1
(fr)
|
2004-02-18 |
2006-11-08 |
AstraZeneca AB |
Composes
|
ES2315851T3
(es)
|
2004-02-19 |
2009-04-01 |
Solvay Pharmaceuticals B.V. |
Derivados de imidazolina que tienen actividad antagonista cb1.
|
BRPI0507786A
(pt)
|
2004-02-20 |
2007-07-17 |
Astrazeneca Ab |
composto e sais farmaceuticamente aceitáveis do mesmo, formulação farmacêutica, uso de um composto, método de tratar uma doença, e, processo para a preparação de compostos
|
GB0403780D0
(en)
|
2004-02-20 |
2004-03-24 |
Astrazeneca Ab |
Therapeutic agents
|
WO2005080424A2
(fr)
|
2004-02-23 |
2005-09-01 |
Rheoscience A/S |
Analogues du peptide yy
|
WO2005082859A1
(fr)
|
2004-02-25 |
2005-09-09 |
Eli Lilly And Company |
2,3,4,5-tetrahydro-1h-benzo[d]azepines substitues en position 6 en tant qu'agonistes de recepteur 5-ht2c
|
US7902191B2
(en)
|
2004-02-25 |
2011-03-08 |
Eli Lilly And Company |
Histamine H3 receptor antagonists, preparation and therapeutic uses
|
DE102004010194A1
(de)
|
2004-03-02 |
2005-10-13 |
Aventis Pharma Deutschland Gmbh |
4-Benzimidazol-2-yl-pyridazin-3-on-Derivate, ihre Herstellung und Verwendung in Arzneimitteln
|
CN1934103B
(zh)
|
2004-03-04 |
2011-06-01 |
橘生药品工业株式会社 |
稠杂环衍生物,包含稠杂环衍生物的药物组合物及其医药用途
|
WO2005085200A1
(fr)
|
2004-03-05 |
2005-09-15 |
Banyu Pharmaceutical Co., Ltd. |
Dérivé pyridone
|
CA2558506C
(fr)
|
2004-03-10 |
2012-09-11 |
Janssen Pharmaceutica N.V. |
Piperidines d'aryle ou piperazines substituees par des heterocycles a 5 ramifications inhibant la mtp
|
DE102004012068A1
(de)
|
2004-03-12 |
2005-09-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue alkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel
|
US7795272B2
(en)
|
2004-03-13 |
2010-09-14 |
Boehringer Ingelheim Pharmaceutical, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
|
GB0406378D0
(en)
|
2004-03-22 |
2004-04-21 |
Karobio Ab |
Novel pharmaceutical compositions
|
CN1938286A
(zh)
|
2004-03-29 |
2007-03-28 |
默克公司 |
作为11-β-羟甾类脱氢酶-1抑制剂的二芳基三唑
|
JP2007531744A
(ja)
|
2004-04-05 |
2007-11-08 |
武田薬品工業株式会社 |
6−アザインドール化合物
|
EP1586318A1
(fr)
|
2004-04-05 |
2005-10-19 |
Neuropharma S.A.U. |
Thiazolidinones comme inhibiteurs de GSK-3
|
WO2005097738A1
(fr)
|
2004-04-06 |
2005-10-20 |
Dainippon Sumitomo Pharma Co., Ltd. |
Nouveau derive sulfonamide
|
JP2007532511A
(ja)
|
2004-04-09 |
2007-11-15 |
スミスクライン ビーチャム コーポレーション |
低用量医薬品
|
FR2868780B1
(fr)
|
2004-04-13 |
2008-10-17 |
Sanofi Synthelabo |
Derives de la 1-amino-phthalazine, leur preparation et leur application en therapeutique
|
WO2005108370A1
(fr)
|
2004-04-16 |
2005-11-17 |
Ajinomoto Co., Inc. |
Composés du benzène
|
EP1604988A1
(fr)
|
2004-05-18 |
2005-12-14 |
Sanofi-Aventis Deutschland GmbH |
Dérivés de pyridazinone, méthodes de leur préparation et leur utilisation comme pharmaceutiques
|
AU2005247693A1
(en)
|
2004-05-25 |
2005-12-08 |
Pfizer Products Inc. |
Tetraazabenzo[E]azulene derivatives and analogs thereof
|
US7442693B2
(en)
|
2004-05-28 |
2008-10-28 |
Smithkline Beecham Corporation |
Diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors
|
DE102004026532A1
(de)
|
2004-05-29 |
2006-01-05 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte Oxazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
DE102004028241B4
(de)
*
|
2004-06-11 |
2007-09-13 |
Sanofi-Aventis Deutschland Gmbh |
Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel
|
FR2871463B1
(fr)
|
2004-06-11 |
2006-09-22 |
Merck Sante Soc Par Actions Si |
Derives a structure aroyl-o-piperidine, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en therapeutique
|
CA2570694A1
(fr)
|
2004-06-24 |
2006-02-02 |
Incyte Corporation |
Composes amido et utilisations de ces derniers en tant que produits pharmaceutiques
|
JPWO2006001318A1
(ja)
|
2004-06-24 |
2008-07-31 |
塩野義製薬株式会社 |
スルホンアミド化合物
|
JP2008504274A
(ja)
|
2004-06-24 |
2008-02-14 |
インサイト・コーポレイション |
アミド化合物およびその医薬としての使用
|
JP2008504266A
(ja)
|
2004-06-24 |
2008-02-14 |
イーライ リリー アンド カンパニー |
異脂肪血症を治療するための化合物及び方法
|
TW200606137A
(en)
|
2004-07-02 |
2006-02-16 |
Sankyo Co |
Urea derivatives
|
WO2006017257A2
(fr)
|
2004-07-12 |
2006-02-16 |
Phenomix Corporation |
Derives d'acetidinone
|
DE102004034697A1
(de)
|
2004-07-17 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Mit Diphenylamin oder Diphenylaminderivaten substituierte Salicylthiazole, Verfahren zu deren Herstellung und deren Verwendung
|
FR2873368B1
(fr)
|
2004-07-26 |
2008-01-04 |
Merck Sante Soc Par Actions Si |
Derives de guanidine et leurs utilisations en therapeutique
|
GB0416728D0
(en)
|
2004-07-27 |
2004-09-01 |
7Tm Pharma As |
Medicinal use of receptor ligands
|
FR2873694B1
(fr)
|
2004-07-27 |
2006-12-08 |
Merck Sante Soc Par Actions Si |
Nouveaux aza-indoles inhibiteurs de la mtp et apob
|
JP4690402B2
(ja)
|
2004-07-28 |
2011-06-01 |
エフ.ホフマン−ラ ロシュ アーゲー |
11−β−HSD1インヒビターとしてのアリール−ピリジン誘導体
|
DE102004037554A1
(de)
|
2004-08-03 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 8-Aminoalkylthio-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
ATE472531T1
(de)
|
2004-08-06 |
2010-07-15 |
Merck Sharp & Dohme |
Sulfonylverbindungen als hemmer von 11-beta- hydroxysteroiddehydrogenase-1
|
DE102004038269A1
(de)
|
2004-08-06 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Piperidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102004038270A1
(de)
|
2004-08-06 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Amino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102004038268A1
(de)
|
2004-08-06 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Pyrrolidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2006018150A1
(fr)
|
2004-08-11 |
2006-02-23 |
Boehringer Ingelheim International Gmbh |
Cycles a substitution d-xylopyranosyl-phenyle, medicaments contenant ces composes, leur utilisation, et leur procede de production
|
BRPI0514147A
(pt)
|
2004-08-12 |
2008-05-27 |
Prosidion Ltd |
composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, métodos de tratamento profilático ou terapêutico de uma condição onde a ativação de gk é desejável, de tratamento profilático ou terapêutico da hiperglicemia ou diabete e de prevenção da diabete em um ser humano que demosntra hiperglicemia pré-diabética ou toleráncia à glicose prejudicada, e, processo para a preparação do composto
|
DE102004039507A1
(de)
|
2004-08-14 |
2006-03-02 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 8-Aminoalkoxi-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102004039789A1
(de)
|
2004-08-16 |
2006-03-02 |
Sanofi-Aventis Deutschland Gmbh |
Arylsubstituierte polycyclische Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2006019020A1
(fr)
|
2004-08-16 |
2006-02-23 |
Sankyo Company, Limited |
Urées de substitution
|
BRPI0514372A
(pt)
|
2004-08-18 |
2008-06-10 |
Metabasis Therapeutics Inc |
inibidores de tiazol de frutose 1, 6-bisfosfatase
|
WO2006024627A2
(fr)
|
2004-08-30 |
2006-03-09 |
Janssen Pharmaceutica N.V. |
Derives d'acetamides n-2 adamantanyl-2-phenoxy utilises en tant qu'inhibiteurs de la deshydrogenase 11-beta hydroxysteroide
|
KR20070053243A
(ko)
|
2004-09-11 |
2007-05-23 |
사노피-아벤티스 도이칠란트 게엠베하 |
7-아자인돌 및 ppar 작용제로서의 이의 용도
|
EP1803729A4
(fr)
|
2004-09-29 |
2008-10-01 |
Kissei Pharmaceutical |
Composé hétérocyclique azoté 1-( -d-glycopyranosyl)-3-substitué, préparation thérapeutique contenant ledit composé, et emploi médical dudit composé
|
PT1797042E
(pt)
|
2004-09-29 |
2009-02-12 |
Hoffmann La Roche |
Derivados de indozolona como inibidores de 11b-hsd1
|
JPWO2006038680A1
(ja)
|
2004-10-01 |
2008-05-15 |
萬有製薬株式会社 |
2−アリールカルボキサミド−含窒素複素環化合物
|
EP1796669B1
(fr)
|
2004-10-01 |
2010-09-22 |
Merck Sharp & Dohme Corp. |
Aminopiperidines utilisees comme inhibiteurs de la dipeptidyle peptidase-iv pour le traitement ou la prevention du diabete
|
US7893017B2
(en)
|
2004-10-07 |
2011-02-22 |
Novo Nordisk A/S |
Protracted GLP-1 compounds
|
JP5107713B2
(ja)
|
2004-10-07 |
2012-12-26 |
ノヴォ ノルディスク アー/エス |
遅延性のエキセンディン−4化合物
|
US7550467B2
(en)
|
2004-10-12 |
2009-06-23 |
Schering Corporation |
Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
|
US8138342B2
(en)
|
2004-10-12 |
2012-03-20 |
High Point Pharmacueticals, LLC |
11β-hydroxysteroid dehydrogenase type 1 active spiro compounds
|
JP2006111553A
(ja)
|
2004-10-13 |
2006-04-27 |
Dainippon Sumitomo Pharma Co Ltd |
スルホニルオキシインドール誘導体及びそれを含有する医薬組成物
|
JP2008515972A
(ja)
|
2004-10-13 |
2008-05-15 |
ニューロジェン・コーポレーション |
メラニン濃縮ホルモン受容体のリガンドとしてのアリール置換8−アザビシクロ[3.2.1]オクタン化合物
|
WO2006045564A1
(fr)
|
2004-10-22 |
2006-05-04 |
Smithkline Beecham Corporation |
Derives de xanthine avec activite du recepteur hm74a
|
MX2007004882A
(es)
|
2004-10-22 |
2007-05-09 |
Smithkline Beecham Corp |
Derivados de xantina con actividad de receptor de hm74a.
|
AR051596A1
(es)
|
2004-10-26 |
2007-01-24 |
Irm Llc |
Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios
|
PL1807072T3
(pl)
|
2004-10-29 |
2009-06-30 |
Lilly Co Eli |
Cykloalkilowe pochodne laktamów jako inhibitory 11-ß-HSD1
|
US20090093463A1
(en)
|
2004-11-02 |
2009-04-09 |
Agouron Pharmaceuticals Inc. |
Novel compounds of substituted and unsubtituted adamantyl amides
|
JP2006131559A
(ja)
|
2004-11-05 |
2006-05-25 |
Takeda Chem Ind Ltd |
含窒素複素環化合物
|
EP1666467A1
(fr)
|
2004-11-08 |
2006-06-07 |
Evotec AG |
Inhibiteurs de 11-béta-HSD1
|
EP1659113A1
(fr)
|
2004-11-08 |
2006-05-24 |
Evotec AG |
Inhibiteurs de 11 beta hydroxy stéroid dehydrogenase type 1 (11beta-HSD1)
|
WO2006051662A1
(fr)
|
2004-11-09 |
2006-05-18 |
Taisho Pharmaceutical Co., Ltd. |
Derive de thiazole
|
JP2006160733A
(ja)
|
2004-11-15 |
2006-06-22 |
Taisho Pharmaceut Co Ltd |
シアノフルオロピロリジン誘導体を有効成分として含有する医薬
|
AU2005309606B2
(en)
|
2004-11-29 |
2011-01-06 |
Merck Sharp & Dohme Corp. |
Fused aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
JPWO2006059744A1
(ja)
|
2004-11-30 |
2008-06-05 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤活性化受容体δの活性化剤
|
AU2005311930B9
(en)
|
2004-12-03 |
2009-09-10 |
Merck Sharp & Dohme Corp. |
Substituted piperazines as CB1 antagonists
|
EP1824835A1
(fr)
|
2004-12-03 |
2007-08-29 |
Novo Nordisk A/S |
Composes heteroaromatiques activants de glukokinase
|
DE102004058449A1
(de)
|
2004-12-03 |
2006-06-14 |
Merck Patent Gmbh |
Tetrahydropyranderivate
|
JP2008007405A
(ja)
|
2004-12-07 |
2008-01-17 |
Takeda Chem Ind Ltd |
カルボキサミド誘導体
|
US7795283B2
(en)
|
2004-12-14 |
2010-09-14 |
Astrazeneca Ab |
Oxadiazole derivative as DGAT inhibitors
|
WO2006065826A2
(fr)
|
2004-12-15 |
2006-06-22 |
Merck & Co., Inc. |
Procede de preparation de derives de beta-aminoacides chiraux par hydrogenation asymetrique
|
EP1888544A2
(fr)
|
2004-12-17 |
2008-02-20 |
Takeda San Diego, Inc. |
Inhibiteurs des hydroxystéroides déshydrogénases
|
WO2006072362A1
(fr)
|
2004-12-18 |
2006-07-13 |
Bayer Healthcare Ag |
Derives de (5s)-3-[(s)-fluor(4-trifluoromethylphenyl)methyl]-5,6,7,8-tetrahydroquinolein-5-ol, et leur utilisation en tant qu'inhibiteurs de la proteine de transfert des esters de cholesterol (cetp)
|
JP2006176443A
(ja)
|
2004-12-22 |
2006-07-06 |
Shionogi & Co Ltd |
メラニン凝集ホルモン受容体アンタゴニスト
|
EP1833802A2
(fr)
|
2004-12-23 |
2007-09-19 |
AstraZeneca AB |
Derives de 1,2-diphenyl-imidazole et leur utilisation comme ligands du recepteur cb1
|
PE20060949A1
(es)
|
2004-12-23 |
2006-10-11 |
Arena Pharm Inc |
Derivados fusionados de pirazol como agonistas del receptor de niacina
|
US20080146614A1
(en)
|
2004-12-23 |
2008-06-19 |
Leifeng Cheng |
Therapeutic Agents
|
WO2006067224A2
(fr)
|
2004-12-23 |
2006-06-29 |
Biovitrum Ab (Publ) |
Nouveaux composes
|
BRPI0518651A2
(pt)
|
2004-12-24 |
2008-12-02 |
Dainippon Sumitomo Pharma |
composto, uma prà-droga do mesmo, ou um sal do composto ou prà-droga farmaceuticamente aceitÁvel, composiÇço farmacÊutica, inibidor de dipeptidil peptidase iv, uso de um composto, uma prà-droga do mesmo ou um sal do composto ou prà-droga farmaceuticamente aceitÁvel, e, mÉtodo para tratar diabetes
|
JP4980928B2
(ja)
|
2004-12-24 |
2012-07-18 |
プロシディオン・リミテッド |
Gタンパク質共役受容体(gpr116)作動薬および肥満および糖尿病治療のためのその使用
|
JP5065908B2
(ja)
|
2004-12-24 |
2012-11-07 |
プロシディオン・リミテッド |
Gタンパク質結合受容体作動薬
|
US7635711B2
(en)
|
2004-12-27 |
2009-12-22 |
Boehringer-Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
US7635699B2
(en)
|
2004-12-29 |
2009-12-22 |
Bristol-Myers Squibb Company |
Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
|
WO2006073973A2
(fr)
|
2004-12-31 |
2006-07-13 |
Reddy Us Therapeutics, Inc. |
Nouveaux dérivés de benzylamine en tant qu'inhibiteurs de cetp
|
DE102005000666B3
(de)
|
2005-01-04 |
2006-10-05 |
Sanofi-Aventis Deutschland Gmbh |
Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
CA2594098C
(fr)
|
2005-01-05 |
2014-04-01 |
Abbott Laboratories |
Inhibiteurs de l'enzyme 11-beta-hydroxysteroide deshydrogenase de type 1
|
DE102005001053A1
(de)
|
2005-01-07 |
2006-07-20 |
Merck Patent Gmbh |
Quadratsäurederivate
|
WO2006073167A1
(fr)
|
2005-01-07 |
2006-07-13 |
Ono Pharmaceutical Co., Ltd. |
Derives de la pyrrolidine
|
TW200637839A
(en)
|
2005-01-07 |
2006-11-01 |
Taisho Pharmaceutical Co Ltd |
1-thio-d-glucitol derivatives
|
DE102005002130A1
(de)
|
2005-01-17 |
2006-07-27 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel
|
AU2006207649B2
(en)
|
2005-01-18 |
2009-07-23 |
F. Hoffmann-La Roche Ag |
Morpholines as 5HT2c agonists
|
JP5094412B2
(ja)
|
2005-01-19 |
2012-12-12 |
メルク・シャープ・エンド・ドーム・コーポレイション |
糖尿病治療用又は予防用のジペプチジルペプチダーゼ−iv阻害剤としての二環系ピリミジン
|
JP2008100916A
(ja)
|
2005-01-24 |
2008-05-01 |
Dainippon Sumitomo Pharma Co Ltd |
インドール類およびそれを含む医薬組成物
|
AR053329A1
(es)
|
2005-01-31 |
2007-05-02 |
Tanabe Seiyaku Co |
Derivados de indol utiles como inhibidores de los transportadores de glucosa dependientes del sodio (sglt)
|
JPWO2006082952A1
(ja)
|
2005-02-01 |
2008-06-26 |
武田薬品工業株式会社 |
アミド化合物
|
MX2007009356A
(es)
|
2005-02-03 |
2007-12-07 |
Irm Llc |
Compuestos y composiciones como moduladores de ppar.
|
EP1851197A2
(fr)
|
2005-02-09 |
2007-11-07 |
Microbia, Inc. |
Derives de phenylazetidinone
|
RU2007128987A
(ru)
|
2005-02-15 |
2009-03-27 |
Ново Нордиск А/С (DK) |
3,4-дигидро-1н-изохинолин-2-карбоновой кислоты 5-аминопиридин-2-2-иловые эфиры
|
DE602006019825D1
(de)
|
2005-02-15 |
2011-03-10 |
Kissei Pharmaceutical |
1-substituierte-7-(b-d-glycopyranosyloxy)(aza)indolverbindung und pharmazeutikum, das diese enthält
|
FR2882054B1
(fr)
|
2005-02-17 |
2007-04-13 |
Sanofi Aventis Sa |
Derives de 1,5-diarylpyrrole, leur preparation et leur application en therapeutique
|
FR2882365B1
(fr)
|
2005-02-21 |
2007-09-07 |
Sanofi Aventis Sa |
Derives de 2-(1,5-diphenyl-1h-pyrazol-3-yl)-1,3,4-oxadiazole leur preparation et leur application en therapeutique
|
RU2007135339A
(ru)
|
2005-02-25 |
2009-03-27 |
Такеда Фармасьютикал Компани Лимитед (Jp) |
Производные пиридилуксусной кислоты
|
US20060229250A1
(en)
|
2005-03-09 |
2006-10-12 |
Jian Zhang |
Ghrelin associated peptide and its uses
|
GB0504857D0
(en)
|
2005-03-09 |
2005-04-13 |
Imp College Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
FR2883000B1
(fr)
|
2005-03-14 |
2007-06-01 |
Merck Sante Soc Par Actions Si |
Derives de trifluoromethylbenzamide et leurs utilisations en therapeutique
|
DE102005012873B4
(de)
|
2005-03-19 |
2007-05-03 |
Sanofi-Aventis Deutschland Gmbh |
Aminocarbonyl substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102005012874A1
(de)
|
2005-03-19 |
2006-09-21 |
Sanofi-Aventis Deutschland Gmbh |
Amid substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
TW200700387A
(en)
|
2005-03-21 |
2007-01-01 |
Akzo Nobel Nv |
1-benzylindole-2-carboxamide derivatives
|
WO2006102674A2
(fr)
|
2005-03-24 |
2006-09-28 |
Microbia, Inc. |
Inhibiteurs d'absorption de cholesterol de diphenylheterocycle
|
TW200722432A
(en)
|
2005-03-25 |
2007-06-16 |
Sankyo Co |
Thiazole compounds
|
WO2006103511A1
(fr)
|
2005-03-31 |
2006-10-05 |
Pfizer Products Inc. |
Derives de cyclopentapyridine et de tetrahydroquinoline
|
CN101151244B
(zh)
|
2005-04-01 |
2014-09-03 |
伊莱利利公司 |
组胺h3受体活性剂、制备和治疗用途
|
TWI357902B
(en)
|
2005-04-01 |
2012-02-11 |
Lg Life Science Ltd |
Dipeptidyl peptidase-iv inhibiting compounds, meth
|
ATE435207T1
(de)
|
2005-04-06 |
2009-07-15 |
Hoffmann La Roche |
Pyridin-3-carbonsäureamidderivate als cb1-inverse agonisten
|
WO2006106423A2
(fr)
|
2005-04-07 |
2006-10-12 |
Pfizer Inc. |
Nouveaux composes de derives aminosulfonyles
|
US20090054423A1
(en)
|
2005-04-13 |
2009-02-26 |
Imbriglio Jason E |
Niacin receptor agonists, compositions containing such compounds and methods of treatment
|
ATE453656T1
(de)
|
2005-04-15 |
2010-01-15 |
Boehringer Ingelheim Int |
Glucopyranosyl-substituierte (heteroaryloxy- benzyl)-benzen-derivate als sglt-inhibitoren
|
DE102005017605B4
(de)
|
2005-04-16 |
2007-03-15 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 2-Aminoalkylthio-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
AR053712A1
(es)
|
2005-04-18 |
2007-05-16 |
Neurogen Corp |
Heteroarilos sustituidos, antagonistas de cb1 (receptor 1 canabinoide)
|
CA2605300A1
(fr)
|
2005-04-19 |
2006-10-26 |
Bayer Pharmaceuticals Corporation |
Preparation et utilisation de derives de l'acide aryle alkyle dans le traitement de l'obesite
|
JP5094394B2
(ja)
|
2005-04-20 |
2012-12-12 |
武田薬品工業株式会社 |
縮合複素環化合物
|
DE102005018389A1
(de)
|
2005-04-20 |
2006-10-26 |
Sanofi-Aventis Deutschland Gmbh |
Azolderivate als Inhibitoren von Lipasen und Phospholipasen
|
EP1874779A1
(fr)
|
2005-04-20 |
2008-01-09 |
Pfizer Products Inc. |
Composes heteromatiques acylaminobicycliques tenant lieu de ligands du recepteur cannabinoide
|
JP2008539255A
(ja)
|
2005-04-26 |
2008-11-13 |
マイクロビア インコーポレーテッド |
高コレステロール血症のための4−ビアリーリル−1−フェニルアゼチジン−2−オングルクロニド誘導体
|
EP1876179B1
(fr)
|
2005-04-28 |
2015-03-25 |
Takeda Pharmaceutical Company Limited |
Composés de thiénopyrimidone
|
WO2006121861A2
(fr)
|
2005-05-05 |
2006-11-16 |
Microbia, Inc. |
Inhibiteurs d'absorption de biphenylazetidinone cholesterol
|
WO2006121860A2
(fr)
|
2005-05-06 |
2006-11-16 |
Bayer Pharmaceuticals Corporation |
Agonistes vis-a-vis du recepteur peptidique de type glucagon 1 (glp-1) et procedes pharmacologiques d'utilisation
|
FR2885627B3
(fr)
|
2005-05-10 |
2007-06-22 |
Espace Production Internationa |
Procede de fabrication de lames de revetement de sol et lames issues de ce procede, feuille decor pour panneaux de revetement de sol
|
EP1879860A2
(fr)
|
2005-05-10 |
2008-01-23 |
Microbia Inc. |
Derives de 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone utilises dans le traitement de l'hypercholesterolemie
|
ES2331535T3
(es)
|
2005-05-10 |
2010-01-07 |
Via Pharmaceuticals, Inc. |
Inhibidores de diacilglicerol aciltransferasa.
|
EP1885703A4
(fr)
|
2005-05-11 |
2009-09-02 |
Microbia Inc |
Procedes de production de derives phenoliques 4-biphenylylazetidin-2-one
|
EA012442B1
(ru)
|
2005-05-13 |
2009-10-30 |
Эли Лилли Энд Компани |
Пегилированные соединения glp-1
|
WO2006124490A2
(fr)
|
2005-05-17 |
2006-11-23 |
Schering Corporation |
Heterocycles utilises comme agonistes du recepteur de l'acide nicotinique dans le traitement de la dyslipidemie
|
WO2007046868A2
(fr)
|
2005-05-19 |
2007-04-26 |
Xenon Pharmaceuticals Inc. |
Derives de thiazolidine et leurs utilisations en tant qu’agents therapeutiques
|
WO2007044085A2
(fr)
|
2005-05-19 |
2007-04-19 |
Xenon Pharmaceuticals Inc. |
Composes heteroaryle et leurs utilisations en tant qu'agents therapeutiques
|
WO2007046867A2
(fr)
|
2005-05-19 |
2007-04-26 |
Xenon Pharmaceuticals Inc. |
Derives de piperidine et leurs utilisations comme agents therapeutiques
|
CA2609506A1
(fr)
|
2005-05-25 |
2006-11-30 |
Microbia, Inc. |
Procedes de production d'acides 4-(biphenylyl)azetidin-2-one phosphoniques
|
US7906649B2
(en)
|
2005-05-25 |
2011-03-15 |
Merck Sharp & Dohme Corp. |
Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
|
TW200714597A
(en)
|
2005-05-27 |
2007-04-16 |
Astrazeneca Ab |
Chemical compounds
|
JP2008542365A
(ja)
|
2005-05-31 |
2008-11-27 |
アストラゼネカ・アクチエボラーグ |
新規なmchr1アンタゴニスト並びにmchr1媒介状態及び障害の処置のためのそれらの使用
|
EP1889842A4
(fr)
|
2005-06-08 |
2009-07-29 |
Japan Tobacco Inc |
Composé hétérocyclique
|
US7579360B2
(en)
|
2005-06-09 |
2009-08-25 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
CA2610588A1
(fr)
|
2005-06-10 |
2006-12-21 |
Boehringer Ingelheim International Gmbh |
Mimetiques de glucocorticoides, procedes de fabrication de ceux-ci, compositions pharmaceutiques et leurs utilisations
|
US20090215779A1
(en)
|
2005-06-11 |
2009-08-27 |
Roger John Butlin |
Oxadiazole derivatives as dgat inhibitors
|
WO2006138163A2
(fr)
|
2005-06-15 |
2006-12-28 |
Merck & Co., Inc. |
Composes anti-hypercholesterolemiques
|
MX2007016319A
(es)
|
2005-06-16 |
2008-03-10 |
Pfizer |
Derivados de n-(piridin-2-il)-sulfonamida.
|
WO2006134481A1
(fr)
|
2005-06-16 |
2006-12-21 |
Pfizer Inc. |
Inhibiteurs de la 11-beta hydroxysteroide deshydrogenase de type 1
|
TW200726765A
(en)
|
2005-06-17 |
2007-07-16 |
Bristol Myers Squibb Co |
Triazolopyridine cannabinoid receptor 1 antagonists
|
WO2006133926A1
(fr)
|
2005-06-17 |
2006-12-21 |
Carex Sa |
Derives de pyrazole utilises comme modulateurs du recepteur cannabinoide
|
UY29607A1
(es)
|
2005-06-20 |
2007-01-31 |
Astrazeneca Ab |
Compuestos quimicos
|
AR056866A1
(es)
|
2005-06-22 |
2007-10-31 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, una formulacion farmaceutica y un proceso de preparacion del compuesto
|
CA2612079A1
(fr)
|
2005-06-22 |
2006-12-28 |
F. Hoffmann-La Roche Ag |
( 6-fluorobenzo[1,3]dioxolyl)-morpholin-4-yl-methanones et leur emploi en tant que ligands de cb1
|
AR057383A1
(es)
|
2005-06-22 |
2007-12-05 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
|
AR057380A1
(es)
|
2005-06-22 |
2007-11-28 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos
|
SA06270191B1
(ar)
|
2005-06-22 |
2010-03-29 |
استرازينيكا ايه بي |
مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
|
AR054482A1
(es)
|
2005-06-22 |
2007-06-27 |
Astrazeneca Ab |
Derivados de azetidinona para el tratamiento de hiperlipidemias
|
MY148538A
(en)
|
2005-06-22 |
2013-04-30 |
Astrazeneca Ab |
Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
|
WO2007001939A1
(fr)
|
2005-06-27 |
2007-01-04 |
Janssen Pharmaceutica N.V. |
Composes tetrahydro-pyranopyrazole presentant des activites de modulation de cannabinoïde
|
WO2007000445A1
(fr)
|
2005-06-29 |
2007-01-04 |
Boehringer Ingelheim International Gmbh |
Derives de benzyle-benzene a substitution glucopyranosyle, medicaments contenant de tels composes, utilisation et production de ces derniers
|
EP1909791A1
(fr)
|
2005-06-30 |
2008-04-16 |
Prosidion Limited |
Agonistes du récepteur couplé aux protéines g
|
GB0513692D0
(en)
|
2005-07-04 |
2005-08-10 |
Karobio Ab |
Novel pharmaceutical compositions
|
EP1904455B1
(fr)
|
2005-07-05 |
2011-08-17 |
F. Hoffmann-La Roche AG |
Derives de pyridazine
|
JPWO2007007688A1
(ja)
|
2005-07-08 |
2009-01-29 |
持田製薬株式会社 |
3,5−ジアミノ−1,2,4−トリアゾール誘導体
|
CA2613303C
(fr)
|
2005-07-11 |
2012-06-19 |
Mitsubishi Tanabe Pharma Corporation |
Un derive d'oxime pour une utilisation comme activateur de la glucokinase
|
JP2007022943A
(ja)
|
2005-07-13 |
2007-02-01 |
Dai Ichi Seiyaku Co Ltd |
スクアレン合成酵素阻害薬
|
EP1905769B1
(fr)
|
2005-07-13 |
2017-03-29 |
Msd K.K. |
Dérivé du benzimidazole à substitution par un hétérocycle
|
US7884210B2
(en)
|
2005-07-14 |
2011-02-08 |
Novo Nordisk A/S |
Ureido-thiazole glucokinase activators
|
ES2326952B1
(es)
|
2005-07-15 |
2010-05-28 |
Laboratorios Del Dr. Esteve, S.A. |
Hidratos de (rac) -n-piperidinil-5-(4-clorofenil)-1-(2,4-diclorofenil)4,5-dihidro-1h-pirazol-3-carboxamida.
|
ES2326461B1
(es)
|
2005-07-15 |
2010-04-19 |
Laboratorios Del Dr. Esteve, S.A. |
Polimorfo de n-priperidinil-5-(4-clorofenil)-1-(2,4-dicloforenil)-4,5-dihidro-1h-pirazol-3-carboxamida y su uso como modulador de receptores de cannabinoides.
|
EP1757587A1
(fr)
|
2005-07-15 |
2007-02-28 |
Laboratorios Del Dr. Esteve, S.A. |
Composés de pyrazoline substituée, leur préparation et leur usage comme médicaments
|
MX2007016024A
(es)
|
2005-07-18 |
2008-03-10 |
Novo Nordisk As |
Peptidos novedosos para el uso en el tratamiento contra la obesidad.
|
KR20080036041A
(ko)
|
2005-07-19 |
2008-04-24 |
머크 앤드 캄파니 인코포레이티드 |
아세틸 조효소 카복실라제(acc) 억제제로서의스피로크로마논 유도체
|
ATE432259T1
(de)
|
2005-07-20 |
2009-06-15 |
Lilly Co Eli |
Pyridinderivate als dipeptedyl-peptidase-hemmer
|
JP2009501733A
(ja)
|
2005-07-20 |
2009-01-22 |
メルク フロスト カナダ リミテツド |
ステアロイルコエンザイムaデルタ−9デサチュラーゼの阻害剤としてのヘテロ芳香族化合物
|
WO2007015744A1
(fr)
|
2005-07-21 |
2007-02-08 |
Incyte Corporation |
Composés thiényl bi-substitués et leur utilisation en tant que produits pharmaceutiques
|
EP1910359B1
(fr)
|
2005-07-21 |
2009-11-18 |
F. Hoffmann-Roche AG |
Composes pyrido [2, 3-d]pyrimidine-2, 4-diamine utilises comme inhibiteurs de ptp1b
|
ATE480524T1
(de)
|
2005-07-21 |
2010-09-15 |
Hoffmann La Roche |
Pyridazinonderivate als schilddrüsenhormon- rezeptoragonisten
|
FR2889189A1
(fr)
|
2005-07-28 |
2007-02-02 |
Cerep Sa |
Composes derives d'hydantoine et leur utilistion en tant qu'antagonistes de mchr-1
|
UY29694A1
(es)
|
2005-07-28 |
2007-02-28 |
Boehringer Ingelheim Int |
Metodos para prevenir y tratar trastornos metabolicos y nuevos derivados de pirazol-o-glucosido
|
EP1916234B1
(fr)
|
2005-07-29 |
2014-11-12 |
Takeda Pharmaceutical Company Limited |
Composé d'acide cyclopropanecarboxylique
|
WO2007017124A1
(fr)
|
2005-07-29 |
2007-02-15 |
Laboratorios Del Dr. Esteve, S.A. |
Phase amorphe d'une pyrazoline substituee, sa preparation et son utilisation comme medicament
|
WO2007016460A2
(fr)
|
2005-07-29 |
2007-02-08 |
Mayo Foundation For Medical Education And Research |
Reduction de la pression exercee sur la peau pour prevenir les escarres de decubitus par levitation magnetique partielle
|
JP2009505962A
(ja)
|
2005-07-29 |
2009-02-12 |
バイエル・ヘルスケア・エルエルシー |
肥満を治療するためのビフェニルアミノ酸誘導体の製造および使用
|
WO2007013691A1
(fr)
|
2005-07-29 |
2007-02-01 |
Takeda Pharmaceutical Company Limited |
Composé spiro-cyclique
|
FR2889190A1
(fr)
|
2005-08-01 |
2007-02-02 |
Merck Sante Soc Par Actions Si |
Nouveaux derives d'imidazoles carboxamides comme inhibiteurs de fructose -1,6-biphosphatase et compositions pharmaceutiques les contenant
|
EP1909797A4
(fr)
|
2005-08-02 |
2013-02-27 |
Neurogen Corp |
Dipipérazinyl cétones et analogues apparentés
|
ES2267400B1
(es)
|
2005-08-04 |
2008-03-01 |
Universitat De Valencia |
Composiciones pigmentarias en base acuosa para marcado policromatico de materiales inorganicos con laser.
|
CA2617654A1
(fr)
|
2005-08-04 |
2007-02-08 |
Pfizer Limited |
Composes piperidinoyl-pyrrolidine et piperidinoyl-piperidine
|
CN101282953A
(zh)
|
2005-08-08 |
2008-10-08 |
阿斯利康(瑞典)有限公司 |
治疗剂
|
JP2009504621A
(ja)
|
2005-08-09 |
2009-02-05 |
アストラゼネカ アクチボラグ |
糖尿病の処置のためのヘテロアリールカルバモイルベンゼン誘導体
|
GB0516462D0
(en)
|
2005-08-10 |
2005-09-14 |
Smithkline Beecham Corp |
Novel compounds
|
US20100216758A1
(en)
|
2005-08-10 |
2010-08-26 |
Makoto Ando |
Pyridone Compounds
|
AR055369A1
(es)
|
2005-08-10 |
2007-08-22 |
Smithkline Beecham Corp |
Compuestos derivados de xantina, su uso para preparar un medicamento para el tratamiento de una enfermedad mediada por el receptor hm74a, formulaciones y combinacion farmaceuticas que la comprenden y metodo de preparacion de los mismos
|
WO2007020502A2
(fr)
|
2005-08-16 |
2007-02-22 |
Pharmacia & Upjohn Company Llc |
Ligands des recepteurs de cannabinoide et utilisations de ceux-ci
|
WO2007020213A2
(fr)
|
2005-08-18 |
2007-02-22 |
F. Hoffmann-La Roche Ag |
Derives de thiazolylpiperidines
|
JPWO2007024004A1
(ja)
|
2005-08-24 |
2009-03-05 |
萬有製薬株式会社 |
フェニルピリドン誘導体
|
JP5075125B2
(ja)
|
2005-08-26 |
2012-11-14 |
メルク・シャープ・エンド・ドーム・コーポレイション |
糖尿病の治療又は予防用ジペプチジルペプチダーゼiv阻害剤としての縮合アミノピペリジン
|
WO2007026215A1
(fr)
|
2005-08-29 |
2007-03-08 |
Glenmark Pharmaceuticals S.A. |
Dérivés de pyrazole tels que les ligands du récepteur de cannabinoïde, compositions pharmaceutiques les contenant et procédés pour leur préparation
|
JP2009507791A
(ja)
|
2005-08-29 |
2009-02-26 |
メルク エンド カムパニー インコーポレーテッド |
ナイアシン受容体アゴニスト、このような化合物を含有する組成物、および治療方法
|
US20090281142A1
(en)
|
2005-08-31 |
2009-11-12 |
Astellas Pharma Inc. |
Thiazole derivative
|
JP2007063225A
(ja)
|
2005-09-01 |
2007-03-15 |
Takeda Chem Ind Ltd |
イミダゾピリジン化合物
|
WO2007028145A2
(fr)
|
2005-09-02 |
2007-03-08 |
Dara Biosciences, Inc. |
Agents et procede permettant de reduire l'activite de la proteine tyrosine phosphatase 1b dans le systeme nerveux central
|
US20080300251A1
(en)
|
2005-09-05 |
2008-12-04 |
Sattigeri Jitendra A |
Derivatives of 3-Azabicyclo[3.1.0] Hexane as Dipeptidyl Peptidase-IV Inhibitors
|
EP1939194A4
(fr)
|
2005-09-07 |
2010-12-08 |
Banyu Pharma Co Ltd |
Dérivé de pyridone substitué aromatique bicylique
|
ES2289888B1
(es)
|
2005-09-08 |
2008-12-16 |
Consejo Superior Investig. Cientificas |
Derivados de pirazolcarboxamida, su procedimiento de obtencion y sus aplicaciones como antagonistas/agonistas inversos del receptor cannabinoide cb1 y opioide mu.
|
CA2621949A1
(fr)
|
2005-09-14 |
2007-03-22 |
Amgen Inc. |
Acides propanoiques 3-substitues par un groupement 4-hydroxyphenyle a conformation contrainte pouvant etre employes dans le traitement de troubles metaboliques
|
GB0518819D0
(en)
|
2005-09-15 |
2005-10-26 |
Astrazeneca Ab |
Therapeutic agents
|
GB0518817D0
(en)
|
2005-09-15 |
2005-10-26 |
Astrazeneca Ab |
Therapeutic agents
|
CA2619093A1
(fr)
|
2005-09-16 |
2007-03-29 |
Arena Pharmaceuticals, Inc. |
Modulateurs du metabolisme et le traitement de troubles s'y rapportant
|
US20090105263A1
(en)
|
2005-09-16 |
2009-04-23 |
Peter William Rodney Caulkett |
Heterobicyclic compounds as glucokinase activators
|
EP1934254A1
(fr)
|
2005-09-21 |
2008-06-25 |
7TM Pharma A/S |
Agonistes selectifs du recepteur y4 pour applications therapeutiques
|
GB0519294D0
(en)
|
2005-09-21 |
2005-11-02 |
Karobio Ab |
Compounds
|
JP2009508886A
(ja)
|
2005-09-21 |
2009-03-05 |
7ティーエム ファーマ エイ/エス |
治療的介入のためのy2選択性レセプターアゴニスト
|
WO2007038138A2
(fr)
|
2005-09-21 |
2007-04-05 |
Incyte Corporation |
Utilisation pharmaceutique de composes amido
|
CN101312724A
(zh)
|
2005-09-23 |
2008-11-26 |
詹森药业有限公司 |
四氢-吲唑基大麻素调节剂
|
PL1931335T3
(pl)
|
2005-09-23 |
2010-07-30 |
Janssen Pharmaceutica Nv |
Modulatory heksahydrocyklooktylopirazolokannabinoidowe
|
JP2007091649A
(ja)
|
2005-09-29 |
2007-04-12 |
Taisho Pharmaceut Co Ltd |
ピリミジン誘導体及びその使用に関連する治療方法
|
EP1940842B1
(fr)
|
2005-09-29 |
2012-05-30 |
Merck Sharp & Dohme Corp. |
Dérivés acylés de spiropipéridine en tant que modulateurs du récepteur de la mélanocortine-4
|
BRPI0616465A2
(pt)
|
2005-09-29 |
2011-06-21 |
Sanofi Aventis |
derivados de fenil-[1,2,4]-oxadiazol-5-ona com grupo fenila, bem como seu uso, composição farmacêutica compreendo os mesmos e processo de preparação da referida composição farmacêutica
|
GT200600429A
(es)
|
2005-09-30 |
2007-04-30 |
|
Compuestos organicos
|
AU2006295645B2
(en)
|
2005-09-30 |
2011-09-29 |
Msd K.K. |
2-heteroaryl-substituted indole derivative
|
CA2624535A1
(fr)
|
2005-09-30 |
2007-04-05 |
Compugen Ltd. |
Variants d'epissure du recepteur du facteur de croissance des hepatocytes et methodes d'utilisation
|
ATE429428T1
(de)
|
2005-09-30 |
2009-05-15 |
Hoffmann La Roche |
Indanderivate als antagonisten des mch-rezeptors
|
US20100167986A1
(en)
|
2005-09-30 |
2010-07-01 |
Amjad Ali |
Cholesteryl Ester Transfer Protein Inhibitors
|
JP2009510069A
(ja)
|
2005-09-30 |
2009-03-12 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン−4受容体作働薬としてのアシル化ピペリジン誘導体
|
GT200600428A
(es)
|
2005-09-30 |
2007-05-21 |
|
Compuestos organicos
|
AR056560A1
(es)
|
2005-10-06 |
2007-10-10 |
Astrazeneca Ab |
Pirrolopiridinonas como moduladores cb1
|
FR2891825B1
(fr)
|
2005-10-12 |
2007-12-14 |
Sanofi Aventis Sa |
Derives de la 1-amino-isoquinoline, leur preparation et leur application en therapeutique
|
DE102005048897A1
(de)
|
2005-10-12 |
2007-04-19 |
Sanofi-Aventis Deutschland Gmbh |
Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen
|
FR2891828B1
(fr)
|
2005-10-12 |
2007-12-21 |
Sanofi Aventis Sa |
Derives de la 1-amino-phtalazine substituee, leur preparation et leur application en therapeutique
|
FR2891829A1
(fr)
|
2005-10-12 |
2007-04-13 |
Sanofi Aventis Sa |
Derives de la 4-amino-quinazoline, leur preparation et leur application en therapeutique
|
JP2009013065A
(ja)
|
2005-10-14 |
2009-01-22 |
Astellas Pharma Inc |
縮合へテロ環化合物
|
US20070105819A1
(en)
|
2005-10-17 |
2007-05-10 |
Roger Olsson |
CB-1 modulating compounds and their use
|
EP1940393B1
(fr)
|
2005-10-20 |
2012-07-25 |
Merck Sharp & Dohme Corp. |
Dérivés de triazol en tant qu'inhibiteurs de 11-bêta-hydroxystéroïde déshydrogénase-1
|
US8188097B2
(en)
|
2005-10-21 |
2012-05-29 |
Mitsubishi Tanabe Pharma Corporation |
Pyrazolo[1,5-A]pyrimidine compounds
|
US7745447B2
(en)
|
2005-10-26 |
2010-06-29 |
Bristol-Myers Squibb Company |
Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonists
|
US8618115B2
(en)
|
2005-10-26 |
2013-12-31 |
Bristol-Myers Squibb Company |
Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them
|
CN101296906A
(zh)
|
2005-10-26 |
2008-10-29 |
贝林格尔·英格海姆国际有限公司 |
具有mch拮抗活性的(杂)芳基化合物及包含这些化合物的药物
|
EP1948190A2
(fr)
|
2005-11-01 |
2008-07-30 |
Transtech Pharma |
Utilisation pharmaceutique des amides substitués
|
JP2009513611A
(ja)
|
2005-11-01 |
2009-04-02 |
ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー |
置換アミドの医薬用途
|
CA2628274A1
(fr)
|
2005-11-01 |
2007-05-10 |
Array Biopharma Inc. |
Activateurs de glucokinase
|
EP1960386A2
(fr)
|
2005-11-01 |
2008-08-27 |
Janssen Pharmaceutica N.V. |
Cycloalkylpyrrolones substitues utilises en tant que modulateurs allosteriques de glucokinase
|
US20080293741A1
(en)
|
2005-11-03 |
2008-11-27 |
Matthew Colin Thor Fyfe |
Tricyclo Substituted Amides as Glucokinase Modulators
|
CA2626475A1
(fr)
|
2005-11-03 |
2007-05-10 |
Prosidion Limited |
Amides a substitution tricyclo
|
BRPI0618067A2
(pt)
|
2005-11-03 |
2011-08-16 |
Prosidion Ltd |
composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso e processo para a preparação de um composto ou um sal farmaceuticamente aceitável do mesmo
|
EP1960343B1
(fr)
|
2005-11-08 |
2012-04-04 |
Laboratorios del Dr. Esteve S.A. |
Derives d'indene, leur preparation et leur utilisation en tant que medicaments
|
US20070114078A1
(en)
|
2005-11-09 |
2007-05-24 |
Ososanya Esther T |
Super hybrid and enhanced electric cars
|
WO2007081755A2
(fr)
|
2006-01-09 |
2007-07-19 |
Metabasis Therapeutics, Inc. |
Inhibiteurs indoliques, benzimidazoliques et indazoliques des tyrosine phosphatases
|
UY30082A1
(es)
|
2006-01-11 |
2007-08-31 |
Boehringer Ingelheim Int |
Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentos
|
JP2009525954A
(ja)
|
2006-01-13 |
2009-07-16 |
シェーリング コーポレイション |
Cb1モジュレーターとしてのジアリールピペリジン
|
KR20080097426A
(ko)
|
2006-01-18 |
2008-11-05 |
쉐링 코포레이션 |
칸나비노이드 수용체 조절제
|